Immunome, Inc. (IMNM) Net margin 2023–2025
Immunome, Inc. (IMNM) net profit margin by fiscal year — reported net income divided by reported revenue.
-3060.0%FY2025 · since FY2023: -761.9% → -3060.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3060.0% | +180.4 pp |
| FY2024 | -3240.4% | -2478.5 pp |
| FY2023 | -761.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice